-+ 0.00%
-+ 0.00%
-+ 0.00%

Vera Therapeutics shareholders elect Class II directors at annual meeting

PUBT·05/26/2026 20:55:18
Listen to the news
Vera Therapeutics shareholders elect Class II directors at annual meeting
  • Vera Therapeutics held its annual shareholder meeting on May 21, 2026.
  • Shareholders selected three Class II directors to serve through the 2029 annual meeting.
  • KPMG was ratified as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
  • Shareholders backed a non-binding advisory resolution on executive pay.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-239559), on May 26, 2026, and is solely responsible for the information contained therein.